Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA)
NCT02781480
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Leber Congenital Amaurosis
Interventions
BIOLOGICAL:
AAV RPE65
Sponsor
MeiraGTx UK II Ltd